Published in Ann Oncol on August 01, 2004
Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. J Clin Oncol (2014) 3.89
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol (2012) 3.08
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol (2009) 1.74
Randomized scheduling feasibility study of S-1 for adjuvant chemotherapy in advanced head and neck cancer. Br J Cancer (2005) 1.21
Head and neck cancer: an evolving treatment paradigm. Cancer (2008) 1.21
Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma. Head Neck (2009) 1.17
An updated overview of HPV-associated head and neck carcinomas. Oncotarget (2014) 1.06
Long-term outcome and patterns of failure in patients with advanced head and neck cancer. Radiat Oncol (2011) 1.02
The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy. Am J Clin Oncol (2011) 0.94
Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma. Cancer (2013) 0.94
Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells. PLoS One (2013) 0.93
Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck. Strahlenther Onkol (2009) 0.91
Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res (2013) 0.90
Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck. Head Neck (2013) 0.89
Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy. Acta Otorhinolaryngol Ital (2012) 0.87
Sensitive HPV detection in oropharyngeal cancers. BMC Cancer (2009) 0.85
Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis. PLoS One (2012) 0.84
Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck. Exp Ther Med (2013) 0.84
MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma. J Oncol (2011) 0.80
Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes. J Contemp Brachytherapy (2015) 0.79
Mononuclear phagocytes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2009) 0.79
Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic. Radiat Oncol (2016) 0.79
Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma. Cancer Biol Ther (2015) 0.79
Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. Oral Oncol (2015) 0.78
Molecular characterization of head and neck cancer: how close to personalized targeted therapy? Mol Diagn Ther (2012) 0.78
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. J Clin Oncol (2006) 0.78
Induction chemotherapy of docetaxel and Cisplatin for the elderly patients with squamous cell carcinoma of the head and neck. Cancer Res Treat (2007) 0.78
Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck. Head Neck (2014) 0.78
EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab. Chemother Res Pract (2012) 0.78
Salvage surgery for head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2014) 0.77
Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis. BMC Cancer (2016) 0.77
Identifying the risk factors for late-stage head and neck cancer. Expert Rev Anticancer Ther (2011) 0.77
The use of epidermal growth factor receptor monoclonal antibodies in squamous cell carcinoma of the head and neck. Chemother Res Pract (2012) 0.77
Prevalence of head and neck cancers in Ahmedabad, Gujarat. Indian J Otolaryngol Head Neck Surg (2009) 0.75
Distinct Gene Profiles for Tumor and Non-Tumor Tissue in the Head and Neck: An Analytical Approach. J Cancer Sci Ther (2011) 0.75
Second-line treatment of recurrent HNSCC: tumor debulking in combination with high-dose-rate brachytherapy and a simultaneous cetuximab-paclitaxel protocol. Radiat Oncol (2016) 0.75
Hyperfractionated radiotherapy with concurrent cisplatin/5-Fluorouracil for locoregional advanced head and neck cancer: analysis of 105 consecutive patients. Int J Otolaryngol (2012) 0.75
Induction chemotherapy followed by radiotherapy in patients with cervical lymph node metastases from unknown primary carcinoma. Indian J Otolaryngol Head Neck Surg (2014) 0.75
Image-guided high-dose-rate brachytherapy of head and neck - a case series study. J Contemp Brachytherapy (2016) 0.75
The use of short segment free jejunal transfer as salvage surgery for cervical esophageal and hypopharyngeal cancer. World J Surg (2014) 0.75
The biological significance of methylome differences in human papilloma virus associated head and neck cancer. Oncol Lett (2016) 0.75
Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET. PLoS One (2016) 0.75
Conditional Survival Analysis of Patients With Locally Advanced Laryngeal Cancer: Construction of a Dynamic Risk Model and Clinical Nomogram. Sci Rep (2017) 0.75
Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence. Radiat Oncol J (2017) 0.75
Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer. J Contemp Brachytherapy (2016) 0.75
Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases. Int J Clin Oncol (2014) 0.75
Disease control and clinicopathological prognostic factors of total pharyngolaryngectomy for hypopharyngeal cancer: a single-center study. Int J Clin Oncol (2014) 0.75
Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes. Oncotarget (2017) 0.75
Adoptive immunotherapy combined with FP treatment for head and neck cancer: An in vitro study. Int J Oncol (2017) 0.75
Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy. Drug Des Devel Ther (2017) 0.75
Identification of a putative second T-cell receptor. Nature (1986) 7.90
A community-based study of chronic fatigue syndrome. Arch Intern Med (1999) 6.04
A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med (1992) 5.10
Lung cancer. Lancet (2000) 3.93
Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol (1991) 3.50
Assessing the impact of total quality management and organizational culture on multiple outcomes of care for coronary artery bypass graft surgery patients. Med Care (2000) 3.17
A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent. Fertil Steril (1982) 2.80
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J (2002) 2.77
Histopathologic findings of duodenal biopsy specimens in HIV-infected patients with and without diarrhea and malabsorption. Am J Clin Pathol (1992) 2.74
A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer. Ann Oncol (2002) 2.42
Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res (2000) 2.28
The chromosome constitution of 1000 human spermatozoa. Hum Genet (1983) 2.21
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol (2003) 2.09
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J Clin Oncol (1996) 2.07
Determinants of gastroesophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both? Ann Intern Med (1992) 2.06
Chromosomal analysis of sperm from men with idiopathic infertility using sperm karyotyping and fluorescence in situ hybridization. Fertil Steril (1995) 1.93
Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas. Neurosurgery (1997) 1.90
Pharyngeal effects of bolus volume, viscosity, and temperature in patients with dysphagia resulting from neurologic impairment and in normal subjects. J Speech Hear Res (1994) 1.76
Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. Cancer Res (1994) 1.72
Incidence and patient characteristics associated with silent aspiration in the acute care setting. Dysphagia (1999) 1.71
Closure mechanisms of laryngeal vestibule during swallow. Am J Physiol (1992) 1.67
Functional results of primary closure vs flaps in oropharyngeal reconstruction: a prospective study of speech and swallowing. Arch Otolaryngol Head Neck Surg (1998) 1.66
Prevention of barium aspiration during videofluoroscopic swallowing studies: value of change in posture. AJR Am J Roentgenol (1993) 1.66
Sentinel lymph node radiolocalization in head and neck squamous cell carcinoma. Laryngoscope (2000) 1.65
5-Fluorouracil cardiotoxicity: a critical review. Ann Oncol (1990) 1.64
Chin-down posture effect on aspiration in dysphagic patients. Arch Phys Med Rehabil (1993) 1.60
Effects of postural change on aspiration in head and neck surgical patients. Otolaryngol Head Neck Surg (1994) 1.59
Changes in pharyngeal dimensions effected by chin tuck. Arch Phys Med Rehabil (1993) 1.56
Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope (1996) 1.56
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst (2001) 1.55
Effects of bolus volume, viscosity, and repeated swallows in nonstroke subjects and stroke patients. Arch Phys Med Rehabil (1993) 1.53
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. Ann Oncol (2008) 1.52
Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol (2004) 1.51
A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost (1993) 1.50
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev (2001) 1.50
Variation in the frequency and type of sperm chromosomal abnormalities among normal men. Hum Genet (1987) 1.46
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res (1996) 1.44
Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma. Blood (1996) 1.44
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol (1994) 1.44
Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemost (1994) 1.43
Immunoglobulin subclasses in normal children. Pediatr Res (1979) 1.42
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am (1999) 1.42
Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency. J Clin Oncol (1991) 1.39
Laparoscopic pelvic lymph node dissection: a review of 103 consecutive cases. J Urol (1994) 1.39
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest (1995) 1.39
Age variation in the association between angiographic coronary disease and angina from the Coronary Artery Surgery Study (CASS) Int J Cardiol (1989) 1.37
Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. J Neurol Neurosurg Psychiatry (2002) 1.36
Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 gene. Cancer Res (2001) 1.35
Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A (1998) 1.33
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut (1997) 1.32
Inappropriate use and unmet need in paramedic and nonparamedic ambulance systems. Ann Emerg Med (1987) 1.32
Swallowing and tongue function following treatment for oral and oropharyngeal cancer. J Speech Lang Hear Res (2000) 1.32
Primary malignant melanoma of the esophagus. Ann Thorac Surg (1995) 1.30
Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med (1986) 1.29
Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery (1999) 1.28
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study. J Clin Oncol (2000) 1.28
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck. Ann Oncol (2012) 1.27
Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol (1999) 1.27
Primary immunodeficiency diseases: an update. Clin Exp Immunol (2003) 1.27
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol (2000) 1.26
Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts. Cancer Treat Rep (1987) 1.25
Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus. Ann Oncol (2005) 1.25
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol (2008) 1.25
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol (2000) 1.24
The effect of age on the frequency of sperm chromosomal abnormalities in normal men. Am J Hum Genet (1987) 1.21
Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody. J Immunol (1989) 1.21
Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients. Otolaryngol Head Neck Surg (1998) 1.21
Identification of a closely linked DNA marker, DXS178, to further refine the X-linked agammaglobulinemia locus. Genomics (1990) 1.21
Neutropenic enterocolitis: two case reports of long-term survival following surgery. Cancer (1979) 1.21
Summer sun exposure: knowledge, attitudes, and behaviors of Midwest adolescents. Prev Med (1997) 1.20
Super-supraglottic swallow in irradiated head and neck cancer patients. Head Neck (1997) 1.20
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol (2001) 1.18
Speech and swallowing function after oral and oropharyngeal resections: one-year follow-up. Head Neck (1994) 1.17
Impaired deglutitive airway protection: a videofluoroscopic analysis of severity and mechanism. Gastroenterology (1997) 1.17
Normal swallowing physiology as viewed by videofluoroscopy and videoendoscopy. Folia Phoniatr Logop (1999) 1.15
Combined modality therapy of head and neck cancer. Semin Oncol (1994) 1.12
Establishment and characterization of a neuroendocrine skin carcinoma cell line. Lab Invest (1987) 1.12
Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol (1998) 1.12
Kinetics of gametogenesis. I. Comparative histological and autoradiographic studies of oocytes and transitional prospermatogonia during oogenesis and prespermatogenesis. Cell Tissue Res (1974) 1.11
Skin cancer control practices among physicians in a university general medicine practice. J Gen Intern Med (1995) 1.11